Navicam for Detection of Barrett's Esophagus
ConditionBarrett's Esophagus
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22+
SponsorMayo Clinic
About this trial
Using a non-invasive capsule system to achieve optimal viewing angles of the esophagus for detection of Barrett's esophagus
Eligibility criteria
Qualifiers
Adults greater than or equal to 22 years of age with or without Barrett's Esophagus
Presence of at least 1cm of salmon colored mucosa with corresponding biopsies showing intestinal metaplasia who are treatment naïve and undergoing surveillance Or
Chronic Gastro Esophageal Reflux Disease (GERD) patients with at least 3 additional risk factors that meet Barrett's Esophagus screening criteria per latest clinical guidelines
Disqualifiers
Inability to comprehend or read the consent form
Have an oropharynx, esophageal, or gastro-esophageal tumor
Ongoing symptoms of dysphagia
Presence of active clinically significant stricture
Trial design
Treatments tested in this trial
- NaviCam Detachable String Capsule
Treatment groups
57 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov